Answers are grounded in this paper and cite their sources.
5][16] Both cellular and humoral SARS-CoV-2 Spike Specific immune responses of the adaptive immune system rises with each vaccine dose, whereas progressively reduce with higher comorbidity prevalence and older age (Figure 1). 17A previous study demonstrated lower spike-protein antibody levels in individuals with medical conditions and those with 50 years of age and older in double Sino pharm vaccinated group, whereas a booster dose of Pfizer/BioNTechBNT162b2 vaccine critically increased spike-protein antibody levels. 18
No takes yet. Share an insight, caveat, or question.
Cheepsattayakorn et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: